Approval · Notice of Compliance 15212 · 2014
RECOTHROM: Notice of Compliance 15212
Issued February 7, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15212
- Date
- February 7, 2014
- Company
- The Medicines Company
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
- Therapeutic class
- Coagulation factor
Products in this notice
Medicinal ingredients
- THROMBIN ALFA 6,000 UNIT per VIAL
- THROMBIN ALFA 24,000 UNIT per VIAL